Presage Biosciences Receives $3,100,000 New Financing Round

  • Feed Type
  • Date
    3/16/2010
  • Company Name
    Presage Biosciences
  • Mailing Address
    Undisclosed Seattle, WA 98101
  • Company Description
    Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors. Frustrated by a lack of tools to identify pre-existing resistance to oncology drugs in his patients, Dr. Olson’s team developed a strategy to assess tumor responses to drug treatments empirically, before subjecting patients to a treatment cycle, frequently with side effects. Presage is using Dr. Olson’s invention to improve the lives of cancer patients though drug development applications.
  • Website
    http://www.presagebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,100,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The idea at Presage is to radically improve the odds that cancer drug candidates will successfully navigate through clinical trials.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.